Brielle Benyon

January 27, 2023

The Food and Drug Administration approved Jaypirca for patients with relapsed/refractory mantle cell lymphoma who have been previously treated with multiple lines of therapy.

January 27, 2023

From Michael Bublé opening up about his son’s cancer diagnosis to the death of “Enkyboys” social media star, here’s what’s happening in the oncology space this week.

January 27, 2023

VIC-1911 will be studied alone or with Lumakras in patients with KRAS G12C-mutant non-small cell lung cancer.

January 26, 2023

The Food and Drug Administration approved Keytruda, an immunotherapy agent, for patients with stage 1B, 2 or 3A non-small cell lung cancer.

January 26, 2023

Researchers just launched a phase 2 trial evaluating iadademstat plus paclitaxel in patients with relapsed/refractory neuroendocrine cancer, including those with small cell lung cancer.

January 25, 2023

Opdivo — even when given in a low dose — was shown to improve outcomes in patients with advanced head and neck squamous cell carcinoma, highlighting a new option for patients who cannot receive the full dose.

January 24, 2023

Patients with pancreatic cancer who underwent stereotactic body radiation tended to have fewer side effects and treatment sessions compared to those who had intensity-modulated radiation therapy.

January 24, 2023

A phase 2 study will investigate the efficacy of darovasertib for patients with uveal melanoma and whether the drug can potentially result in lower radiation doses or fewer eye removal surgeries.

January 23, 2023

Patients who underwent minimally invasive treatment tended to have better quality-of-life outcomes than those who had a full esophagus removal, though there were risk factors for long-term outcomes that should be considered.

January 23, 2023

We surveyed the CURE® audience about how cancer impacted their relationship with their hair. Here’s what they had to say.

January 22, 2023

Patients with gastric cancer who quit smoking and/or drinking after undergoing a gastrectomy tended to have a decreased risk of depression, research showed.

January 20, 2023

From Tennis star Chris Evert’s cancer-free status to Duran Duran’s Andy Taylor talking about his prostate cancer, here’s what’s happening in the oncology space this week.

January 20, 2023

Lytgobi was approved for pretreated cholangiocarcinoma in September, and updated study findings support the drug’s continued approval.

January 19, 2023

The Food and Drug Administration approved Brukinsa for patients with chronic lymphocytic leukemia or small lymphocytic leukemia.

January 19, 2023

The FDA approved Tukysa plus Herceptin for previously treated patients with HER2-positive metastatic colorectal cancer.

January 18, 2023

The COVALENT-102 trial will investigate BMF-219 in patients with non-small cell lung cancer, colorectal and pancreatic cancers.

January 18, 2023

A test that measures tumor DNA in the blood could be a helpful prognostic factor in patients with colorectal cancer who underwent surgery.

January 17, 2023

While some may say that teaching breathing techniques gives patients with cancer the “heebie-jeebies”, it can actually have a major impact on patients’ pain and stress, according to an expert.

January 17, 2023

Immune-based therapies have not been as successful in childhood cancer as they have been with adults, but ongoing research is hoping to change that.

January 17, 2023

The Food and Drug Administration is speeding up the review and potential approval of Padcev plus Keytruda for certain patients with urothelial carcinoma, the most common form of bladder cancer.

January 16, 2023

Virtual oncology visits may lessen the financial toxicity of cancer treatments, according to recent research.

January 13, 2023

From the cancer diagnoses of an MLB pitcher and star of Riverdance to First Lady Jill Biden’s recent carcinoma removal, here’s what’s happening in the cancer space this week.

January 12, 2023

Poor body composition was associated with increased risk of death in men with localized prostate cancer, according to recent study findings.

January 11, 2023

More than half of patients with low- or intermediate-risk prostate cancer who underwent treatment with Erleada had no evidence of residual disease after 90 days, a recent study showed.

January 10, 2023

Rickey and Marla Briskman’s marriage has grown as both have navigated the roles of patient with cancer and caregiver.

January 10, 2023

Treatment with tovorafenib led to a 64% overall response rate in patients with recurrent or progressive pediatric low-grade glioma, study findings showed.

January 09, 2023

TAVT-45, a drug that can be mixed with juice or water, showed similar efficacy in treating metastatic castration-resistant prostate cancer as Zytiga.

January 06, 2023

Imetelstat improves eight- and 24-week transfusion independence in patients with low-risk myelodysplastic syndrome, according to topline study results.

January 06, 2023

From tennis star Martina Navratilova’s two cancer diagnoses to First Lady Jill Biden undergoing Mohs surgery to have a suspicious lesion removed and musician deaths, here’s what’s happening in the cancer space this week.

January 04, 2023

A novel three-drug combination bested standard-of-care regimens for patients with human papillomavirus-related cancers, according to phase 2 study results.